MediWound (MDWD) Change in Accured Expenses (2015 - 2025)
MediWound's (MDWD) quarterly Change in Accured Expenses came in at $3000.0 in Q2 2025, up 101.02% year-on-year from $1492.4 in Q2 2024, and down 99.88% quarter-over-quarter from $2.5 million in Q4 2024.
MediWound (MDWD) Change in Accured Expenses (2015 - 2025) Analysis & Trends
MediWound's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $3000.0 for Q2 2025.
- On a quarterly basis, Change in Accured Expenses rose 101.02% year-over-year to $3000.0 in Q2 2025; TTM through Jun 2025 was $2.1 million, a 441.8% increase from a year earlier, with the FY2024 full-year figure at $517000.0, up 187.04% from the prior year.
- Change in Accured Expenses retreated to $3000.0 in Q2 2025 per MDWD's latest filing, from $2.5 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.5 million in Q4 2024 and bottomed at -$2.0 million in Q2 2022.
- The 5-year median for Change in Accured Expenses is $3000.0 (2025), against an average of -$59823.5.
- Across the five-year window, Change in Accured Expenses soared 49600.0% in 2021 and sank 15637.5% in 2022, its largest moves.
- Year by year, Change in Accured Expenses stood at $990000.0 in 2021, then dropped by 20.81% to $784000.0 in 2022, then jumped by 39.41% to $1.1 million in 2023, then jumped by 125.53% to $2.5 million in 2024, then sank by 99.88% to $3000.0 in 2025.
- Per Business Quant, the three latest MDWD Change in Accured Expenses figures stand at $3000.0 (Q2 2025), $2.5 million (Q4 2024), and -$48000.0 (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -16.82 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -16.74 Mn |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Dec 31, 2024 | 2.47 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | -48,000.00 |
| Sep 30, 2024 | -48,000.00 |
| Jun 30, 2024 | -294,000.00 |
| Jun 30, 2024 | -294,000.00 |
| Mar 31, 2024 | -1.37 Mn |
| Mar 31, 2024 | -1.37 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | -51,000.00 |
| Sep 30, 2023 | -51,000.00 |
| Jun 30, 2023 | -1.36 Mn |
| Jun 30, 2023 | -1.36 Mn |
| Mar 31, 2023 | -1.95 Mn |
| Mar 31, 2023 | -1.95 Mn |
| Dec 31, 2022 | 784,000.00 |
| Dec 31, 2022 | 784,000.00 |